...
search icon
derm-img

Journey Medical Corp, Common Stock

DERM

NAQ

$6.78

-$0.19

(-2.73%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$172.16M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
71.02K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.88
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.54 L
$8.25 H
$6.78

About Journey Medical Corp, Common Stock

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameDERMSectorS&P500
1-Week Return-8.25%1.81%0.78%
1-Month Return7.28%3.75%2.88%
3-Month Return26.97%-4.88%9.45%
6-Month Return33.2%-2.96%-0.12%
1-Year Return26.26%-6.25%11.31%
3-Year Return89.92%12.43%61.11%
5-Year Return-31.52%39.86%96.65%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue44.53M63.13M73.67M79.18M56.13M[{"date":"2020-12-31","value":56.24,"profit":true},{"date":"2021-12-31","value":79.73,"profit":true},{"date":"2022-12-31","value":93.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":70.89,"profit":true}]
Cost of Revenue14.59M32.08M30.77M26.66M20.88M[{"date":"2020-12-31","value":45.49,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.92,"profit":true},{"date":"2023-12-31","value":83.09,"profit":true},{"date":"2024-12-31","value":65.08,"profit":true}]
Gross Profit29.94M31.05M42.89M52.52M35.26M[{"date":"2020-12-31","value":57,"profit":true},{"date":"2021-12-31","value":59.12,"profit":true},{"date":"2022-12-31","value":81.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":67.13,"profit":true}]
Gross Margin67.23%49.18%58.23%66.33%62.81%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":73.16,"profit":true},{"date":"2022-12-31","value":86.61,"profit":true},{"date":"2023-12-31","value":98.67,"profit":true},{"date":"2024-12-31","value":93.42,"profit":true}]
Operating Expenses22.09M56.39M70.41M54.59M48.93M[{"date":"2020-12-31","value":31.37,"profit":true},{"date":"2021-12-31","value":80.09,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.54,"profit":true},{"date":"2024-12-31","value":69.49,"profit":true}]
Operating Income7.85M(25.34M)(27.52M)(2.07M)(13.68M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-322.77,"profit":false},{"date":"2022-12-31","value":-350.49,"profit":false},{"date":"2023-12-31","value":-26.4,"profit":false},{"date":"2024-12-31","value":-174.21,"profit":false}]
Total Non-Operating Income/Expense(1.40M)(14.51M)(4.01M)(3.59M)(2.88M)[{"date":"2020-12-31","value":-139600000,"profit":false},{"date":"2021-12-31","value":-1451100000,"profit":false},{"date":"2022-12-31","value":-400700000,"profit":false},{"date":"2023-12-31","value":-359100000,"profit":false},{"date":"2024-12-31","value":-287700000,"profit":false}]
Pre-Tax Income7.15M(42.36M)(29.57M)(3.63M)(14.61M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-592.2,"profit":false},{"date":"2022-12-31","value":-413.32,"profit":false},{"date":"2023-12-31","value":-50.78,"profit":false},{"date":"2024-12-31","value":-204.26,"profit":false}]
Income Taxes1.87M1.63M63.00K221.00K61.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":87.38,"profit":true},{"date":"2022-12-31","value":3.37,"profit":true},{"date":"2023-12-31","value":11.82,"profit":true},{"date":"2024-12-31","value":3.26,"profit":true}]
Income After Taxes5.28M(43.99M)(29.63M)(3.85M)(14.67M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-832.75,"profit":false},{"date":"2022-12-31","value":-560.82,"profit":false},{"date":"2023-12-31","value":-72.93,"profit":false},{"date":"2024-12-31","value":-277.72,"profit":false}]
Income From Continuous Operations5.28M(43.99M)(29.63M)(12.35M)(14.67M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-832.75,"profit":false},{"date":"2022-12-31","value":-560.82,"profit":false},{"date":"2023-12-31","value":-233.81,"profit":false},{"date":"2024-12-31","value":-277.72,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income5.28M(43.99M)(29.63M)(3.85M)(14.67M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-832.75,"profit":false},{"date":"2022-12-31","value":-560.82,"profit":false},{"date":"2023-12-31","value":-72.93,"profit":false},{"date":"2024-12-31","value":-277.72,"profit":false}]
EPS (Diluted)-(4.20)(1.68)(0.18)(0.74)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-420,"profit":false},{"date":"2022-12-31","value":-168,"profit":false},{"date":"2023-12-31","value":-18,"profit":false},{"date":"2024-12-31","value":-74,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DERM
Cash Ratio 0.52
Current Ratio 1.34
Quick Ratio 1.03

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DERM
ROA (LTM) -5.70%
ROE (LTM) -48.14%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DERM
Debt Ratio Lower is generally better. Negative is bad. 0.75
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.25

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DERM
Trailing PE NM
Forward PE 14.16
P/S (TTM) 2.86
P/B 7.54
Price/FCF NM
EV/R 2.96
EV/Ebitda 17.72

FAQs

What is Journey Medical Corp share price today?

Journey Medical Corp (DERM) share price today is $6.78

Can Indians buy Journey Medical Corp shares?

Yes, Indians can buy shares of Journey Medical Corp (DERM) on Vested. To buy Journey Medical Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DERM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Journey Medical Corp be purchased?

Yes, you can purchase fractional shares of Journey Medical Corp (DERM) via the Vested app. You can start investing in Journey Medical Corp (DERM) with a minimum investment of $1.

How to invest in Journey Medical Corp shares from India?

You can invest in shares of Journey Medical Corp (DERM) via Vested in three simple steps:

  • Click on Sign Up or Invest in DERM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Journey Medical Corp shares
What is Journey Medical Corp 52-week high and low stock price?

The 52-week high price of Journey Medical Corp (DERM) is $8.25. The 52-week low price of Journey Medical Corp (DERM) is $3.54.

What is Journey Medical Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Journey Medical Corp (DERM) is 7.54

What is the Market Cap of Journey Medical Corp?

The market capitalization of Journey Medical Corp (DERM) is $172.16M

What is Journey Medical Corp’s stock symbol?

The stock symbol (or ticker) of Journey Medical Corp is DERM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top